318 related articles for article (PubMed ID: 24773203)
1. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury.
Zhang T; Bao L; Zhao Q; Wu ZE; Dai M; Rao Q; Li F
J Proteome Res; 2023 Jul; 22(7):2327-2338. PubMed ID: 37232578
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.
Li F; Patterson AD; Krausz KW; Tanaka N; Gonzalez FJ
J Lipid Res; 2012 Aug; 53(8):1625-35. PubMed ID: 22665165
[TBL] [Abstract][Full Text] [Related]
5. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
6. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
Kersten S; Stienstra R
Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
[TBL] [Abstract][Full Text] [Related]
7. PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis.
Hu X; Tanaka N; Guo R; Lu Y; Nakajima T; Gonzalez FJ; Aoyama T
J Nutr Biochem; 2017 Jan; 39():77-85. PubMed ID: 27816763
[TBL] [Abstract][Full Text] [Related]
8. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
9. Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress.
Okiyama W; Tanaka N; Nakajima T; Tanaka E; Kiyosawa K; Gonzalez FJ; Aoyama T
J Hepatol; 2009 Jun; 50(6):1236-46. PubMed ID: 19398233
[TBL] [Abstract][Full Text] [Related]
10. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
Yan T; Luo Y; Yan N; Hamada K; Zhao N; Xia Y; Wang P; Zhao C; Qi D; Yang S; Sun L; Cai J; Wang Q; Jiang C; Gavrilova O; Krausz KW; Patel DP; Yu X; Wu X; Hao H; Liu W; Qu A; Gonzalez FJ
Hepatology; 2023 Jan; 77(1):239-255. PubMed ID: 35460276
[TBL] [Abstract][Full Text] [Related]
11. Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate.
Dai M; Hua H; Lin H; Xu G; Hu X; Li F; Gonzalez FJ; Liu A; Yang J
J Proteome Res; 2018 Apr; 17(4):1500-1508. PubMed ID: 29498526
[TBL] [Abstract][Full Text] [Related]
12. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
13. Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity.
Liu A; Krausz KW; Fang ZZ; Brocker C; Qu A; Gonzalez FJ
Arch Toxicol; 2014 Apr; 88(4):983-96. PubMed ID: 24385052
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage.
Nakajima T; Kamijo Y; Tanaka N; Sugiyama E; Tanaka E; Kiyosawa K; Fukushima Y; Peters JM; Gonzalez FJ; Aoyama T
Hepatology; 2004 Oct; 40(4):972-80. PubMed ID: 15382117
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity.
Chen C; Krausz KW; Shah YM; Idle JR; Gonzalez FJ
Chem Res Toxicol; 2009 Apr; 22(4):699-707. PubMed ID: 19256530
[TBL] [Abstract][Full Text] [Related]
16. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse.
Manna SK; Patterson AD; Yang Q; Krausz KW; Li H; Idle JR; Fornace AJ; Gonzalez FJ
J Proteome Res; 2010 Aug; 9(8):4176-88. PubMed ID: 20540569
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function.
Zhu XX; Wang X; Jiao SY; Liu Y; Shi L; Xu Q; Wang JJ; Chen YE; Zhang Q; Song YT; Wei M; Yu BQ; Fielitz J; Gonzalez FJ; Du J; Qu AJ
Acta Pharmacol Sin; 2023 Nov; 44(11):2184-2200. PubMed ID: 37328648
[TBL] [Abstract][Full Text] [Related]
18. Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity.
Luo M; Tan Z; Dai M; Song D; Lin J; Xie M; Yang J; Sun L; Wei D; Zhao J; Gonzalez FJ; Liu A
Arch Toxicol; 2017 Feb; 91(2):897-907. PubMed ID: 27344344
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice.
Xie G; Yin S; Zhang Z; Qi D; Wang X; Kim D; Yagai T; Brocker CN; Wang Y; Gonzalez FJ; Wang H; Qu A
Am J Pathol; 2019 Feb; 189(2):272-282. PubMed ID: 30448405
[TBL] [Abstract][Full Text] [Related]
20. Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice.
Brocker CN; Patel DP; Velenosi TJ; Kim D; Yan T; Yue J; Li G; Krausz KW; Gonzalez FJ
J Lipid Res; 2018 Nov; 59(11):2140-2152. PubMed ID: 30158201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
